Onderneming GlaxoSmithKline Pharmaceuticals Limited
Aandelen
GLAXO
INE159A01016
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.943 INR | +3,26% | -2,38% | +2,41% |
29/02 | Cynata Therapeutics benoemt Chief Business Officer; Aandelen kelderen 14% | MT |
28/02 | Glaxosmithkline Pharmaceuticals Limited benoemt Aparajita Mukherjee Rajput, Technology Lead | CI |
Vakgebied
Aantal werknemers: 3 680
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 32 780 | 100,0 % | 32 517 | 100,0 % | -0,80% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
98,0
%
| 31 961 | 97,5 % | 31 877 | 98,0 % | -0,26% |
Foreign
2,0
%
| 819 | 2,5 % | 640 | 2,0 % | -21,85% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 54 | 01-12-22 |
Juby Chandy
DFI | Director of Finance/CFO | - | 01-04-22 |
Simrat Sohal
CMP | Compliance Officer | - | - |
Priyanka Bhatia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ajay A. Nadkarni
ADM | Chief Administrative Officer | - | 01-12-01 |
Ransom D'Souza
IRO | Public Communications Contact | - | 17-04-17 |
Chinmay Sharma
HRO | Human Resources Officer | - | 01-12-20 |
General Counsel | - | 18-01-17 | |
General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 70 | 01-04-19 |
Manu Anand
BRD | Director/Board Member | 64 | 16-05-22 |
Director/Board Member | 74 | 30-03-15 | |
Director/Board Member | 73 | 04-11-11 | |
Director/Board Member | 70 | 30-03-15 | |
Director/Board Member | 58 | 18-05-20 | |
Subesh Williams
BRD | Director/Board Member | 62 | 07-04-17 |
Juby Chandy
DFI | Director of Finance/CFO | - | 01-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 169 410 000 | 41 365 025 ( 24,42 %) | 0 | 24,42 % |
Bedrijfsgegevens
GlaxoSmithKline Pharmaceuticals Ltd.
GSK House Dr. Annie Besant Road
400030, Mumbai
+91 22 2495 9595
http://www.gsk-india.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Biddle Sawyer Ltd.
|
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,41% | 3,83 mld. | |
+33,50% | 701 mld. | |
+26,24% | 571 mld. | |
+0,78% | 381 mld. | |
+20,85% | 334 mld. | |
+16,38% | 319 mld. | |
+1,11% | 210 mld. | |
+2,73% | 210 mld. | |
-6,50% | 201 mld. | |
-3,51% | 157 mld. |
- Beurs
- Aandelen
- Aandeel GlaxoSmithKline Pharmaceuticals Limited - Bombay S.E.
- Onderneming GlaxoSmithKline Pharmaceuticals Limited